Indeed, recent studies, utilizing genomic sequencing data from human high-grade serous ovarian cancer specimens, have shown that these cancers exhibit genomic instability and harbor genetic mutations in p53, Rb, BRCA1, and/or BRCA2 loci [52]–[55]. This evidence concerns the gene BRCA2 and ovarian serous adenocarcinoma.